AIS

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Antibodies vs. the EPO – What scope of protection?

By AWA | Posted on May 21, 2018

Antibodies are currently enjoying great attention and are, together with their derivations and combined applications, growing to occupy centre position in the therapeutics and diagnostics fields. Indeed, the possible industrial applications have increased many fold since the harvesting of the first monoclonal antibodies by researchers Ehrlich & Metchnikoff, which led to an effective syphilis treatment...

Tags: AIS, antibodies, EPO, US

Recent contributors

Ai-Leen Lim, Partner and Attorney at Law, Hong Kong SAR

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Julia Wang, Senior Associate and Attorney at Law, Beijing, China

Julia Wang

Senior Associate, Attorney at Law

Ylva Strandberg, Counsel and AU and NZ Patent Attorney, Stockholm, Sweden

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li, Senior Associate and China Patent Attorney, Beijing, China

Hongyue Li

Senior Associate, China Patent Attorney

Isa Böttiger, Associate and Attorney at Law, Stockholm, Sweden

Isa Böttiger

Senior Associate, Attorney at Law

Ylva Wikmark, Counsel and European Patent Attorney, Stockholm, Sweden

Ylva Wikmark

Counsel, European Patent Attorney